Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

Market Cap	2.89B +14.2%
Revenue (ttm)	341.90M +61.7%
Net Income	-108.07M
EPS	-0.10
Shares Out	1.03B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,161,049
Average Volume	12,028,191
Open	2.810
Previous Close	2.810
Day's Range	2.790 - 2.830
52-Week Range	1.720 - 2.880
Beta	0.38
RSI	62.57
Earnings Date	Apr 18, 2026

About SHE:000518

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 277
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000518

Financial Performance

In 2024, SHE:000518's revenue was 203.52 million, a decrease of -13.55% compared to the previous year's 235.42 million. Losses were -109.99 million, 46.1% more than in 2023.